Condition: Heel Spur Syndrome · Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Heel Spur Syndrome (HSS), is a pathology characterized by chronic inflammation and degenerative changes that affect approximately 10% of adults. Although many patients respond to conservative care, about 30% experience persistent pain. Low-dose radiation therapy (LDRT) is a well-established European method with proven anti-inflammatory and immunomodulatory effects. The ORHEELS trial aims to assess whether a Polish standard dose of 6 Gy in 6 daily fractions (fx)(5 times/week) is not inferior to the treatment with total dose of 3 Gy / fx 0,5 Gy /fractionated twice weekly. The study is designed to assess the impact of intensity of treatment (daily (5 times / week) versus twice weekly fractionation) on clinical outcomes.
This description comes directly from the study's public registry record.
Iwona Dębosz-Suwińska · +48232789148 · iwona.debosz-suwinska@gliwice.nio.gov.pl
Mateusz Gajek · +48322788063 · mateusz.gajek@gliwice.nio.gov.pl
Always discuss trial participation with your own doctor first.
| Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch | Gliwice, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07546240